Show simple item record

dc.contributor.authorHelderman, Ron C.
dc.contributor.authorWhitney, Daniel G.
dc.contributor.authorDuta-Mare, Madalina
dc.contributor.authorAkhmetshina, Alena
dc.contributor.authorVujic, Nemanja
dc.contributor.authorJayapalan, Shobana
dc.contributor.authorNyman, Jeffry S.
dc.contributor.authorMisra, Biswapriya B.
dc.contributor.authorRosen, Clifford J.
dc.contributor.authorCzech, Michael P.
dc.contributor.authorKratky, Dagmar
dc.contributor.authorRendina-Ruedy, Elizabeth
dc.date2022-08-11T08:09:59.000
dc.date.accessioned2022-08-23T16:51:29Z
dc.date.available2022-08-23T16:51:29Z
dc.date.issued2021-07-01
dc.date.submitted2021-07-26
dc.identifier.citation<p>Helderman RC, Whitney DG, Duta-Mare M, Akhmetshina A, Vujic N, Jayapalan S, Nyman JS, Misra BB, Rosen CJ, Czech MP, Kratky D, Rendina-Ruedy E. Loss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans. Bone. 2021 Jul;148:115946. doi: 10.1016/j.bone.2021.115946. Epub 2021 Apr 7. PMID: 33838322; PMCID: PMC8108562. <a href="https://doi.org/10.1016/j.bone.2021.115946">Link to article on publisher's site</a></p>
dc.identifier.issn1873-2763 (Linking)
dc.identifier.doi10.1016/j.bone.2021.115946
dc.identifier.pmid33838322
dc.identifier.urihttp://hdl.handle.net/20.500.14038/41867
dc.description.abstractLysosomal acid lipase (LAL) is essential for cholesteryl ester (CE) and triacylglycerol (TAG) hydrolysis in the lysosome. Clinically, an autosomal recessive LIPA mutation causes LAL deficiency (LALD), previously described as Wolman Disease or Cholesteryl Ester Storage Disease (CESD). LAL-D is associated with ectopic lipid accumulation in the liver, small intestine, spleen, adrenal glands, and blood. Considering the importance of unesterified cholesterol and fatty acids in bone metabolism, we hypothesized that LAL is essential for bone formation, and ultimately, skeletal health. To investigate the role of LAL in skeletal homeostasis, we used LAL-deficient ((-/-)) mice, in vitro osteoblast cultures, and novel clinical data from LAL-D patients. Both male and female LAL(-/-) mice demonstarted lower trabecular and cortical bone parameters , which translated to reduced biomechanical properties. Further histological analyses revealed that LAL(-/-) mice had fewer osteoblasts, with no change in osteoclast or marrow adipocyte numbers. In studying the cell-autonomous role of LAL, we observed impaired differentiation of LAL(-/-) calvarial osteoblasts and in bone marrow stromal cells treated with the LAL inhibitor lalistat. Consistent with LAL's role in other tissues, lalistat resulted in profound lipid puncta accumulation and an altered intracellular lipid profile. Finally, we analyzed a large de-identified national insurance database (i.e. 2016/2017 Optum Clinformatics(R)) which revealed that adults ( > /=18 years) with CESD (n = 3076) had a higher odds ratio (OR = 1.21; 95% CI = 1.03-1.41) of all-cause fracture at any location compared to adults without CESD (n = 13.7 M) after adjusting for demographic variables and osteoporosis. These data demonstrate that alterations in LAL have significant clinical implications related to fracture risk and that LAL's modulation of lipid metabolism is a critical for osteoblast function.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=33838322&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rights© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBone
dc.subjectCholesterol
dc.subjectLipid
dc.subjectLipophagy
dc.subjectMetabolism
dc.subjectOsteoblast
dc.subjectSkeleton
dc.subjectBiochemical Phenomena, Metabolism, and Nutrition
dc.subjectCell and Developmental Biology
dc.subjectCellular and Molecular Physiology
dc.subjectCongenital, Hereditary, and Neonatal Diseases and Abnormalities
dc.subjectEnzymes and Coenzymes
dc.subjectLipids
dc.subjectMusculoskeletal Diseases
dc.subjectMusculoskeletal System
dc.subjectNutritional and Metabolic Diseases
dc.titleLoss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans
dc.typeJournal Article
dc.source.journaltitleBone
dc.source.volume148
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5704&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/4672
dc.identifier.contextkey24025209
refterms.dateFOA2022-08-23T16:51:29Z
html.description.abstract<p>Lysosomal acid lipase (LAL) is essential for cholesteryl ester (CE) and triacylglycerol (TAG) hydrolysis in the lysosome. Clinically, an autosomal recessive LIPA mutation causes LAL deficiency (LALD), previously described as Wolman Disease or Cholesteryl Ester Storage Disease (CESD). LAL-D is associated with ectopic lipid accumulation in the liver, small intestine, spleen, adrenal glands, and blood. Considering the importance of unesterified cholesterol and fatty acids in bone metabolism, we hypothesized that LAL is essential for bone formation, and ultimately, skeletal health. To investigate the role of LAL in skeletal homeostasis, we used LAL-deficient ((-/-)) mice, in vitro osteoblast cultures, and novel clinical data from LAL-D patients. Both male and female LAL(-/-) mice demonstarted lower trabecular and cortical bone parameters , which translated to reduced biomechanical properties. Further histological analyses revealed that LAL(-/-) mice had fewer osteoblasts, with no change in osteoclast or marrow adipocyte numbers. In studying the cell-autonomous role of LAL, we observed impaired differentiation of LAL(-/-) calvarial osteoblasts and in bone marrow stromal cells treated with the LAL inhibitor lalistat. Consistent with LAL's role in other tissues, lalistat resulted in profound lipid puncta accumulation and an altered intracellular lipid profile. Finally, we analyzed a large de-identified national insurance database (i.e. 2016/2017 Optum Clinformatics(R)) which revealed that adults ( > /=18 years) with CESD (n = 3076) had a higher odds ratio (OR = 1.21; 95% CI = 1.03-1.41) of all-cause fracture at any location compared to adults without CESD (n = 13.7 M) after adjusting for demographic variables and osteoporosis. These data demonstrate that alterations in LAL have significant clinical implications related to fracture risk and that LAL's modulation of lipid metabolism is a critical for osteoblast function.</p>
dc.identifier.submissionpathoapubs/4672
dc.contributor.departmentProgram in Molecular Medicine
dc.source.pages115946


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S8756328221001083_main.pdf
Size:
3.950Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).